Abstract | OBJECTIVES: BACKGROUND: METHODS: We randomly assigned 30 subjects with CAD to combined vitamin E (800 IU per day) and C (1000 mg per day) or to placebos in a double-blind trial. Coronary artery endothelial function was measured as the change in coronary artery diameter to acetylcholine infusions (n = 18 patients), and brachial artery endothelial function was assessed by flow-mediated dilation (n = 25 patients) at baseline and six months. Plasma markers of oxidant stress ( oxidized LDL and autoantibodies) were also measured. RESULTS: CONCLUSIONS: Long-term oral vitamins C and E do not improve key mechanisms in the biology of atherosclerosis or endothelial dysfunction, or reduce LDL oxidation in vivo.
|
Authors | Scott Kinlay, Dominik Behrendt, James C Fang, Danielle Delagrange, Jason Morrow, Joseph L Witztum, Nader Rifai, Andrew P Selwyn, Mark A Creager, Peter Ganz |
Journal | Journal of the American College of Cardiology
(J Am Coll Cardiol)
Vol. 43
Issue 4
Pg. 629-34
(Feb 18 2004)
ISSN: 0735-1097 [Print] United States |
PMID | 14975474
(Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Antioxidants
- Vitamin E
- Ascorbic Acid
|
Topics |
- Antioxidants
(administration & dosage, therapeutic use)
- Ascorbic Acid
(administration & dosage, therapeutic use)
- Brachial Artery
(drug effects)
- Coronary Disease
(drug therapy, physiopathology)
- Coronary Vessels
(drug effects)
- Double-Blind Method
- Drug Therapy, Combination
- Endothelium, Vascular
(drug effects, physiology)
- Female
- Humans
- Male
- Middle Aged
- Oxidative Stress
(drug effects)
- Time Factors
- Vasodilation
(physiology)
- Vitamin E
(administration & dosage, therapeutic use)
|